Trinity Partners, a leading global life sciences consulting firm, today announced it will participate in ISPOR’s 21st Annual International Meeting, May 21-25, in Washington, D.C.
This year’s International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting is designed to bring together thought leaders in health research related to clinical, economic and patient reported outcomes, health policy and patient preferences, and provide an update on how health care systems from around the world are applying real-world data to make real-world decisions.
“Trinity’s philosophy is to provide clients with innovative analyses that produce robust evidence and strategic insights and enable them to make important decisions in today’s dynamic and ever-changing healthcare industry,” said Jillian Godfrey Scaife, Principal, Trinity Partners. “We look forward to attending ISPOR, connecting with members of the pharmaceutical community and showcasing Trinity’s dynamic outcomes research initiatives.”
Trinity experts will participate in a poster presentation at ISPOR:
Finding Potential Predictors of Alzheimer’s Disease Using Medicare Claims Data (May 23, 8:30 – 2:00 p.m.) Gavin Miyasato, associate director of statistics, and Gretchen Chiu, statistician, will present a poster discussing the potential predictors of Alzheimer’s Disease using longitudinal data captured in Medicare claims data.
For more information on Trinity Partners, please visit http://www.trinitypartners.com/ or follow Trinity on Twitter: https://twitter.com/TrinityLifeSci.